Platelets are not just for clots

Transfusion Medicine Reviews

Volumn 29, Issue 2, 2015, Pages 110-119

  McFadyen, James D ^a   Kaplan, Zane S ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Cancer; Inflammation; Leukocytes; Platelets; Thrombosis

Indexed keywords

ANTIINFECTIVE AGENT; ANTITHROMBOCYTIC AGENT; CD40 LIGAND; TOLL LIKE RECEPTOR; CD40 ANTIGEN; FC RECEPTOR;

ATHEROSCLEROSIS; BLOOD TRANSFUSION; CELL ACTIVATION; DISEASE SURVEILLANCE; DISSEMINATED INTRAVASCULAR CLOTTING; ERYTHROCYTE; GRAFT REJECTION; HEMOSTASIS; HUMAN; HUMORAL IMMUNITY; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNE RESPONSE; MACROPHAGE; MALIGNANT NEOPLASTIC DISEASE; MONOCYTE; NONHUMAN; REVIEW; RHEUMATOID ARTHRITIS; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOCYTOPENIA; THROMBOSIS; TRANSFUSION RELATED ACUTE LUNG INJURY; ANIMAL; BACTERIAL INFECTION; BLOOD TRANSFUSION REACTION; IMMUNE SYSTEM; IMMUNOLOGY; INFLAMMATION; LEUKOCYTE; MOUSE; NEOPLASM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; VASCULAR ENDOTHELIUM;

ANIMALS; ANTIGENS, CD40; BACTERIAL INFECTIONS; BLOOD PLATELETS; ENDOTHELIUM, VASCULAR; HEMOSTASIS; HUMANS; IMMUNE SYSTEM; INFLAMMATION; LEUKOCYTES; MICE; NEOPLASMS; RECEPTORS, FC; TOLL-LIKE RECEPTORS; TRANSFUSION REACTION;

EID: 84927098046     PISSN: 08877963     EISSN: 15329496     Source Type: Journal    
DOI: 10.1016/j.tmrv.2014.11.006     Document Type: Review

References (144)

1. Furie B., Furie B.C. Mechanisms of thrombus formation. N Engl J Med 2008, 359(9):938-949.
2. Jackson S.P. The growing complexity of platelet aggregation. Blood 2007, 109(12):5087-5095.
3. Ruggeri Z.M. Platelet adhesion under flow. Microcirculation 2009, 16(1):58-83.
4. McFadyen J.D., Jackson S.P. Differentiating haemostasis from thrombosis for therapeutic benefit. Thromb Haemost 2013, 110(5):859-867.
5. Lopez J.A., Andrews R.K., Afshar-Kharghan V., Berndt M.C. Bernard-Soulier syndrome. Blood 1998, 91(12):4397-4418.
6. George J.N., Caen J.P., Nurden A.T. Glanzmann's thrombasthenia: the spectrum of clinical disease. Blood 1990, 75(7):1383-1395.
7. Ruggeri Z.M., Mendolicchio G.L. Adhesion mechanisms in platelet function. Circ Res 2007, 100(12):1673-1685.
8. Andrews R.K., Lopez J.A., Berndt M.C. Molecular mechanisms of platelet adhesion and activation. Int J Biochem Cell Biol 1997, 29(1):91-105.
9. Semple J.W., Italiano J.E., Freedman J. Platelets and the immune continuum. Nat Rev Immunol 2011, 11(4):264-274.
10. Macaulay I.C., Carr P., Gusnanto A., Ouwehand W.H., Fitzgerald D., Watkins N.A. Platelet genomics and proteomics in human health and disease. J Clin Invest 2005, 115(12):3370-3377.
11. Coppinger J.A., Cagney G., Toomey S., Kislinger T., Belton O., McRedmond J.P., et al. Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions. Blood 2004, 103(6):2096-2104.
12. Wijten P., van Holten T., Woo L.L., Bleijerveld O.B., Roest M., Heck A.J., et al. High precision platelet releasate definition by quantitative reversed protein profiling-brief report. Arterioscler Thromb Vasc Biol 2013, 33(7):1635-1638.
13. Vieira-de-Abreu A., Rondina M.T., Weyrich A.S., Zimmerman G.A. Inflammation. Platelets 2013, 733-765. Academic Press, Amsterdam. A.D. Michelson (Ed.).
14. Yeaman M.R. Platelets in defense against bacterial pathogens. Cell Mol Life Sci 2010, 67(4):525-544.
15. Vieira-de-Abreu A., Campbell R.A., Weyrich A.S., Zimmerman G.A. Platelets: versatile effector cells in hemostasis, inflammation, and the immune continuum. Semin Immunopathol 2012, 34(1):5-30.
16. Fitzgerald J.R., Foster T.J., Cox D. The interaction of bacterial pathogens with platelets. Nat Rev Microbiol 2006, 4(6):445-457.
17. Youssefian T., Drouin A., Masse J.M., Guichard J., Cramer E.M. Host defense role of platelets: engulfment of HIV and Staphylococcus aureus occurs in a specific subcellular compartment and is enhanced by platelet activation. Blood 2002, 99(11):4021-4029.
18. Yong E.C., Chi E.Y., Fritsche T.R., Henderson W.R. Human platelet-mediated cytotoxicity against Toxoplasma gondii: role of thromboxane. J Exp Med 1991, 173(1):65-78.
19. McMorran B.J., Marshall V.M., de Graaf C., Drysdale K.E., Shabbar M., Smyth G.K., et al. Platelets kill intraerythrocytic malarial parasites and mediate survival to infection. Science 2009, 323(5915):797-800.
20. van der Heyde H.C., Gramaglia I., Sun G., Woods C. Platelet depletion by anti-CD41 (alphaIIb) mAb injection early but not late in the course of disease protects against Plasmodium berghei pathogenesis by altering the levels of pathogenic cytokines. Blood 2005, 105(5):1956-1963.
21. Sun G., Chang W.L., Li J., Berney S.M., Kimpel D., van der Heyde H.C. Inhibition of platelet adherence to brain microvasculature protects against severe Plasmodium berghei malaria. Infect Immun 2003, 71(11):6553-6561.
22. Faille D., El-Assaad F., Alessi M.C., Fusai T., Combes V., Grau G.E. Platelet-endothelial cell interactions in cerebral malaria: the end of a cordial understanding. Thromb Haemost 2009, 102(6):1093-1102.
23. Cox D., McConkey S. The role of platelets in the pathogenesis of cerebral malaria. Cell Mol Life Sci 2010, 67(4):557-568.
24. Kasirer-Friede A., Kahn M.L., Shattil S.J. Platelet integrins and immunoreceptors. Immunol Rev 2007, 218:247-264.
25. Warkentin T.E. Heparin-induced thrombocytopenia: pathogenesis and management. Br J Haematol 2003, 121(4):535-555.
26. Watson S.P., Herbert J.M., Pollitt A.Y. GPVI and CLEC-2 in hemostasis and vascular integrity. J Thromb Haemost 2010, 8(7):1456-1467.
27. Suzuki-Inoue K., Inoue O., Ozaki Y. Novel platelet activation receptor CLEC-2: from discovery to prospects. J Thromb Haemost 2011, 9(Suppl. 1):44-55.
28. Suzuki-Inoue K., Fuller G.L., Garcia A., Eble J.A., Pohlmann S., Inoue O., et al. A novel Syk-dependent mechanism of platelet activation by the C-type lectin receptor CLEC-2. Blood 2006, 107(2):542-549.
29. Suzuki-Inoue K., Inoue O., Ding G., Nishimura S., Hokamura K., Eto K., et al. Essential in vivo roles of the C-type lectin receptor CLEC-2: embryonic/neonatal lethality of CLEC-2-deficient mice by blood/lymphatic misconnections and impaired thrombus formation of CLEC-2-deficient platelets. J Biol Chem 2010, 285(32):24494-24507.
30. Kawai T., Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 2010, 11(5):373-384.
31. Akira S., Uematsu S., Takeuchi O. Pathogen recognition and innate immunity. Cell 2006, 124(4):783-801.
32. Semple J.W., Aslam R., Kim M., Speck E.R., Freedman J. Platelet-bound lipopolysaccharide enhances Fc receptor-mediated phagocytosis of IgG-opsonized platelets. Blood 2007, 109(11):4803-4805.
33. Aslam R., Speck E.R., Kim M., Crow A.R., Bang K.W., Nestel F.P., et al. Platelet Toll-like receptor expression modulates lipopolysaccharide-induced thrombocytopenia and tumor necrosis factor-alpha production in vivo. Blood 2006, 107(2):637-641.
34. Stahl A.L., Svensson M., Morgelin M., Svanborg C., Tarr P.I., Mooney J.C., et al. Lipopolysaccharide from enterohemorrhagic Escherichia coli binds to platelets through TLR4 and CD62 and is detected on circulating platelets in patients with hemolytic uremic syndrome. Blood 2006, 108(1):167-176.
35. Andonegui G., Kerfoot S.M., McNagny K., Ebbert K.V., Patel K.D., Kubes P. Platelets express functional Toll-like receptor-4. Blood 2005, 106(7):2417-2423.
36. Clark S.R., Ma A.C., Tavener S.A., McDonald B., Goodarzi Z., Kelly M.M., et al. Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat Med 2007, 13(4):463-469.
37. Blair P., Rex S., Vitseva O., Beaulieu L., Tanriverdi K., Chakrabarti S., et al. Stimulation of Toll-like receptor 2 in human platelets induces a thromboinflammatory response through activation of phosphoinositide 3-kinase. Circ Res 2009, 104(3):346-354.
38. Keane C., Tilley D., Cunningham A., Smolenski A., Kadioglu A., Cox D., et al. Invasive Streptococcus pneumoniae trigger platelet activation via Toll-like receptor 2. J Thromb Haemost 2010, 8(12):2757-2765.
39. Assinger A., Kral J.B., Yaiw K.C., Schrottmaier W.C., Kurzejamska E., Wang Y., et al. Human cytomegalovirus-platelet interaction triggers toll-like receptor 2-dependent proinflammatory and proangiogenic responses. Arterioscler Thromb Vasc Biol 2014, 34(4):801-809.
40. Panigrahi S., Ma Y., Hong L., Gao D., West X.Z., Salomon R.G., et al. Engagement of platelet toll-like receptor 9 by novel endogenous ligands promotes platelet hyperreactivity and thrombosis. Circ Res 2013, 112(1):103-112.
41. Thon J.N., Peters C.G., Machlus K.R., Aslam R., Rowley J., Macleod H., et al. T granules in human platelets function in TLR9 organization and signaling. J Cell Biol 2012, 198(4):561-574.
42. Antoniades C., Bakogiannis C., Tousoulis D., Antonopoulos A.S., Stefanadis C. The CD40/CD40 ligand system: linking inflammation with atherothrombosis. J Am Coll Cardiol 2009, 54(8):669-677.
43. Henn V., Slupsky J.R., Grafe M., Anagnostopoulos I., Forster R., Muller-Berghaus G., et al. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 1998, 391(6667):591-594.
44. Heeschen C., Dimmeler S., Hamm C.W., van den Brand M.J., Boersma E., Zeiher A.M., et al. Soluble CD40 ligand in acute coronary syndromes. N Engl J Med 2003, 348(12):1104-1111.
45. Schonbeck U., Libby P. The CD40/CD154 receptor/ligand dyad. Cell Mol Life Sci 2001, 58(1):4-43.
46. Elzey B.D., Ratliff T.L., Sowa J.M., Crist S.A. Platelet CD40L at the interface of adaptive immunity. Thromb Res 2011, 127(3):180-183.
47. Kroczek R.A., Graf D., Brugnoni D., Giliani S., Korthuer U., Ugazio A., et al. Defective expression of CD40 ligand on T cells causes "X-linked immunodeficiency with hyper-IgM (HIGM1)". Immunol Rev 1994, 138:39-59.
48. Allen R.C., Armitage R.J., Conley M.E., Rosenblatt H., Jenkins N.A., Copeland N.G., et al. CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science 1993, 259(5097):990-993.
49. Khan S.Y., Kelher M.R., Heal J.M., Blumberg N., Boshkov L.K., Phipps R., et al. Soluble CD40 ligand accumulates in stored blood components, primes neutrophils through CD40, and is a potential cofactor in the development of transfusion-related acute lung injury. Blood 2006, 108(7):2455-2462.
50. Schonbeck U., Libby P. CD40 signaling and plaque instability. Circ Res 2001, 89(12):1092-1103.
51. Gawaz M., Neumann F.J., Ott I., Schiessler A., Schomig A. Platelet function in acute myocardial infarction treated with direct angioplasty. Circulation 1996, 93(2):229-237.
52. Gawaz M., Langer H., May A.E. Platelets in inflammation and atherogenesis. J Clin Invest 2005, 115(12):3378-3384.
53. Frenette P.S., Denis C.V., Weiss L., Jurk K., Subbarao S., Kehrel B., et al. P-Selectin glycoprotein ligand 1 (PSGL-1) is expressed on platelets and can mediate platelet-endothelial interactions in vivo. J Exp Med 2000, 191(8):1413-1422.
54. Romo G.M., Dong J.F., Schade A.J., Gardiner E.E., Kansas G.S., Li C.Q., et al. The glycoprotein Ib-IX-V complex is a platelet counterreceptor for P-selectin. J Exp Med 1999, 190(6):803-814.
55. Davi G., Patrono C. Platelet activation and atherothrombosis. N Engl J Med 2007, 357(24):2482-2494.
56. Gawaz M., Langer H., May A. Platelets in inflammation and atherogenesis. J Clin Investig 2005, 115(12):3378-3384.
57. Massberg S., Brand K., Gruner S., Page S., Muller E., Muller I., et al. A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation. J Exp Med 2002, 196(7):887-896.
58. Belton O.A., Duffy A., Toomey S., Fitzgerald D.J. Cyclooxygenase isoforms and platelet vessel wall interactions in the apolipoprotein E knockout mouse model of atherosclerosis. Circulation 2003, 108(24):3017-3023.
59. McEver R.P., Cummings R.D. Perspectives series: cell adhesion in vascular biology. Role of PSGL-1 binding to selectins in leukocyte recruitment. J Clin Invest 1997, 100(3):485-491.
60. Simon D.I., Chen Z., Xu H., Li C.Q., Dong J., McIntire L.V., et al. Platelet glycoprotein ibalpha is a counterreceptor for the leukocyte integrin Mac-1 (CD11b/CD18). J Exp Med 2000, 192(2):193-204.
61. Diacovo T.G., deFougerolles A.R., Bainton D.F., Springer T.A. A functional integrin ligand on the surface of platelets: intercellular adhesion molecule-2. J Clin Invest 1994, 94(3):1243-1251.
62. Santoso S., Sachs U.J., Kroll H., Linder M., Ruf A., Preissner K.T., et al. The junctional adhesion molecule 3 (JAM-3) on human platelets is a counterreceptor for the leukocyte integrin Mac-1. J Exp Med 2002, 196(5):679-691.
63. Weber C., Springer T.A. Neutrophil accumulation on activated, surface-adherent platelets in flow is mediated by interaction of Mac-1 with fibrinogen bound to alphaIIbbeta3 and stimulated by platelet-activating factor. J Clin Invest 1997, 100(8):2085-2093.
64. Gleissner C.A., von Hundelshausen P., Ley K. Platelet chemokines in vascular disease. Arterioscler Thromb Vasc Biol 2008, 28(11):1920-1927.
65. Zlotnik A., Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 2000, 12(2):121-127.
66. Klinger M.H., Wilhelm D., Bubel S., Sticherling M., Schroder J.M., Kuhnel W. Immunocytochemical localization of the chemokines RANTES and MIP-1 alpha within human platelets and their release during storage. Int Arch Allergy Immunol 1995, 107(4):541-546.
67. Smyth S.S., McEver R.P., Weyrich A.S., Morrell C.N., Hoffman M.R., Arepally G.M., et al. Platelet functions beyond hemostasis. J Thromb Haemost 2009, 7(11):1759-1766.
68. Ghasemzadeh M., Kaplan Z.S., Alwis I., Schoenwaelder S.M., Ashworth K.J., Westein E., et al. The CXCR1/2 ligand NAP-2 promotes directed intravascular leukocyte migration through platelet thrombi. Blood 2013, 121(22):4555-4566.
69. von Hundelshausen P., Petersen F., Brandt E. Platelet-derived chemokines in vascular biology. Thromb Haemost 2007, 97(5):704-713.
70. Holt J.C., Rabellino E.M., Gewirtz A.M., Gunkel L.M., Rucinski B., Niewiarowski S. Occurrence of platelet basic protein, a precursor of low affinity platelet factor 4 and beta-thromboglobulin, in human platelets and megakaryocytes. Exp Hematol 1988, 16(4):302-306.
71. Brandt E., Van Damme J., Flad H.D. Neutrophils can generate their activator neutrophil-activating peptide 2 by proteolytic cleavage of platelet-derived connective tissue-activating peptide III. Cytokine 1991, 3(4):311-321.
72. Schiemann F., Grimm T.A., Hoch J., Gross R., Lindner B., Petersen F., et al. Mast cells and neutrophils proteolytically activate chemokine precursor CTAP-III and are subject to counterregulation by PF-4 through inhibition of chymase and cathepsin G. Blood 2006, 107(6):2234-2242.
73. von Hundelshausen P., Koenen R.R., Weber C. Platelet-mediated enhancement of leukocyte adhesion. Microcirculation 2009, 16(1):84-96.
74. Walz A., Baggiolini M. A novel cleavage product of beta-thromboglobulin formed in cultures of stimulated mononuclear cells activates human neutrophils. Biochem Biophys Res Commun 1989, 159(3):969-975.
75. Brandt E., Ludwig A., Petersen F., Flad H.D. Platelet-derived CXC chemokines: old players in new games. Immunol Rev 2000, 177:204-216.
76. Hagiwara H., Mitsumata M., Yamane T., Jin X., Yoshida Y. Laminar shear stress-induced GRO mRNA and protein expression in endothelial cells. Circulation 1998, 98(23):2584-2590.
77. Lira S.A., Furtado G.C. The biology of chemokines and their receptors. Immunol Res 2012, 54(1-3):111-120.
78. Smith D.F., Galkina E., Ley K., Huo Y. GRO family chemokines are specialized for monocyte arrest from flow. Am J Physiol Heart Circ Physiol 2005, 289(5):H1976-H1984.
79. Power C.A., Furness R.B., Brawand C., Wells T.N. Cloning of a full-length cDNA encoding the neutrophil-activating peptide ENA-78 from human platelets. Gene 1994, 151(1-2):333-334.
80. Gear A.R., Camerini D. Platelet chemokines and chemokine receptors: linking hemostasis, inflammation, and host defense. Microcirculation 2003, 10(3-4):335-350.
81. Moser B., Clark-Lewis I., Zwahlen R., Baggiolini M. Neutrophil-activating properties of the melanoma growth-stimulatory activity. J Exp Med 1990, 171(5):1797-1802.
82. Holmes W.E., Lee J., Kuang W.J., Rice G.C., Wood W.I. Structure and functional expression of a human interleukin-8 receptor. Science 1991, 253(5025):1278-1280.
83. Boehlen F., Clemetson K.J. Platelet chemokines and their receptors: what is their relevance to platelet storage and transfusion practice?. Transfus Med 2001, 11(6):403-417.
84. Rollins B.J. Chemokines. Blood 1997, 90(3):909-928.
85. Kaplan Z.S., Jackson S.P. The role of platelets in atherothrombosis. Hematology Am Soc Hematol Educ Program 2011, 2011:51-61.
86. Jennings L.K. Role of platelets in atherothrombosis. Am J Cardiol 2009, 103(3 Suppl):4A-10A.
87. Schonbeck U., Sukhova G.K., Shimizu K., Mach F., Libby P. Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice. Proc Natl Acad Sci U S A 2000, 97(13):7458-7463.
88. Lutgens E., Cleutjens K.B., Heeneman S., Koteliansky V.E., Burkly L.C., Daemen M.J. Both early and delayed anti-CD40L antibody treatment induces a stable plaque phenotype. Proc Natl Acad Sci U S A 2000, 97(13):7464-7469.
89. Shaz B.H., Stowell S.R., Hillyer C.D. Transfusion-related acute lung injury: from bedside to bench and back. Blood 2011, 117(5):1463-1471.
90. Bux J., Sachs U.J. The pathogenesis of transfusion-related acute lung injury (TRALI). Br J Haematol 2007, 136(6):788-799.
91. Caudrillier A., Kessenbrock K., Gilliss B.M., Nguyen J.X., Marques M.B., Monestier M., et al. Platelets induce neutrophil extracellular traps in transfusion-related acute lung injury. J Clin Invest 2012, 122(7):2661-2671.
92. Chang M., Nakagawa P.A., Williams S.A., et al. Immune thrombocytopenic purpura (ITP) plasma and purified ITP monoclonal autoantibodies inhibit megakaryocytopoiesis in vitro. Blood 2003, 102(3):887-895.
93. Harrington W.J., Minnich V., Hollingsworth J.W., Moore C.V. Demonstration of a thrombocytopenic factor in the blood of patients with thrombocytopenic purpura. J Lab Clin Med 1951, 38(1):1-10.
94. Asahi A., Nishimoto T., Okazaki Y., Suzuki H., Masaoka T., Kawakami Y., et al. Helicobacter pylori eradication shifts monocyte Fcgamma receptor balance toward inhibitory FcgammaRIIB in immune thrombocytopenic purpura patients. J Clin Invest 2008, 118(8):2939-2949.
95. Blajchman M.A. Transfusion-associated immunomodulation and universal white cell reduction: are we putting the cart before the horse?. Transfusion 1999, 39(7):665-670.
96. Gouttefangeas C., Diehl M., Keilholz W., Hornlein R.F., Stevanovic S., Rammensee H.G. Thrombocyte HLA molecules retain nonrenewable endogenous peptides of megakaryocyte lineage and do not stimulate direct allocytotoxicity in vitro. Blood 2000, 95(10):3168-3175.
97. Chapman L.M., Aggrey A.A., Field D.J., Srivastava K., Ture S., Yui K., et al. Platelets present antigen in the context of MHC class I. J Immunol 2012, 189(2):916-923.
98. Aslam R., Speck E.R., Kim M., Freedman J., Semple J.W. Transfusion-related immunomodulation by platelets is dependent on their expression of MHC Class I molecules and is independent of white cells. Transfusion 2008, 48(9):1778-1786.
99. Freedman J.E., Loscalzo J. Platelet-monocyte aggregates: bridging thrombosis and inflammation. Circulation 2002, 105(18):2130-2132.
100. van Gils J.M., Zwaginga J.J., Hordijk P.L. Molecular and functional interactions among monocytes, platelets, and endothelial cells and their relevance for cardiovascular diseases. J Leukoc Biol 2009, 85(2):195-204.
101. Brinkmann V., Reichard U., Goosmann C., Fauler B., Uhlemann Y., Weiss D.S., et al. Neutrophil extracellular traps kill bacteria. Science 2004, 303(5663):1532-1535.
102. Kaplan M.J., Radic M. Neutrophil extracellular traps: double-edged swords of innate immunity. J Immunol 2012, 189(6):2689-2695.
103. Brill A., Fuchs T.A., Savchenko A.S., Thomas G.M., Martinod K., De Meyer S.F., et al. Neutrophil extracellular traps promote deep vein thrombosis in mice. J Thromb Haemost 2012, 10(1):136-144.
104. Fuchs T.A., Brill A., Duerschmied D., Schatzberg D., Monestier M., Myers D.D., et al. Extracellular DNA traps promote thrombosis. Proc Natl Acad Sci U S A 2010, 107(36):15880-15885.
105. von Bruhl M.L., Stark K., Steinhart A., Chandraratne S., Konrad I., Lorenz M., et al. Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J Exp Med 2012, 209(4):819-835.
106. Brinkmann V., Zychlinsky A. Beneficial suicide: why neutrophils die to make NETs. Nat Rev Microbiol 2007, 5(8):577-582.
107. Ma A.C., Kubes P. Platelets, neutrophils, and neutrophil extracellular traps (NETs) in sepsis. J Thromb Haemost 2008, 6(3):415-420.
108. Phillipson M., Kubes P. The neutrophil in vascular inflammation. Nat Med 2011, 17(11):1381-1390.
109. Reid V.L., Webster N.R. Role of microparticles in sepsis. Br J Anaesth 2012, 109(4):503-513.
110. Ogura H., Kawasaki T., Tanaka H., Koh T., Tanaka R., Ozeki Y., et al. Activated platelets enhance microparticle formation and platelet-leukocyte interaction in severe trauma and sepsis. J Trauma 2001, 50(5):801-809.
111. Burnier L., Fontana P., Kwak B.R., Angelillo-Scherrer A. Cell-derived microparticles in haemostasis and vascular medicine. Thromb Haemost 2009, 101(3):439-451.
112. Italiano J.E., Mairuhu A.T., Flaumenhaft R. Clinical relevance of microparticles from platelets and megakaryocytes. Curr Opin Hematol 2010, 17(6):578-584.
113. Mause S.F., von Hundelshausen P., Zernecke A., Koenen R.R., Weber C. Platelet microparticles: a transcellular delivery system for RANTES promoting monocyte recruitment on endothelium. Arterioscler Thromb Vasc Biol 2005, 25(7):1512-1518.
114. Edelstein L.C., McKenzie S.E., Shaw C., Holinstat M.A., Kunapuli S.P., Bray P.F. MicroRNAs in platelet production and activation. J Thromb Haemost 2013, 11(Suppl 1):340-350.
115. Edelstein L.C., Bray P.F. MicroRNAs in platelet production and activation. Blood 2011, 117(20):5289-5296.
116. Risitano A., Beaulieu L.M., Vitseva O., Freedman J.E. Platelets and platelet-like particles mediate intercellular RNA transfer. Blood 2012, 119(26):6288-6295.
117. Tranum B.L., Haut A. Thrombocytosis: platelet kinetics in neoplasia. J Lab Clin Med 1974, 84(5):615-619.
118. Hernandez E., Lavine M., Dunton C.J., Gracely E., Parker J. Poor prognosis associated with thrombocytosis in patients with cervical cancer. Cancer 1992, 69(12):2975-2977.
119. Zeimet A.G., Marth C., Muller-Holzner E., Daxenbichler G., Dapunt O. Significance of thrombocytosis in patients with epithelial ovarian cancer. Am J Obstet Gynecol 1994, 170(2):549-554.
120. Ikeda M., Furukawa H., Imamura H., Shimizu J., Ishida H., Masutani S., et al. Poor prognosis associated with thrombocytosis in patients with gastric cancer. Ann Surg Oncol 2002, 9(3):287-291.
121. Karpatkin S., Pearlstein E., Ambrogio C., Coller B.S. Role of adhesive proteins in platelet tumor interaction in vitro and metastasis formation in vivo. J Clin Invest 1988, 81(4):1012-1019.
122. Gasic G.J., Gasic T.B., Stewart C.C. Antimetastatic effects associated with platelet reduction. Proc Natl Acad Sci U S A 1968, 61(1):46-52.
123. Karpatkin S., Ambrogio C., Pearlstein E. The role of tumor-induced platelet aggregation, platelet adhesion and adhesive proteins in tumor metastasis. Prog Clin Biol Res 1988, 283:585-606.
124. Shau H., Roth M.D., Golub S.H. Regulation of natural killer function by nonlymphoid cells. Nat Immun 1993, 12(4-5):235-249.
125. Philippe C., Philippe B., Fouqueray B., Perez J., Lebret M., Baud L. Protection from tumor necrosis factor-mediated cytolysis by platelets. Am J Pathol 1993, 143(6):1713-1723.
126. Stone J.P., Wagner D.D. P-selectin mediates adhesion of platelets to neuroblastoma and small cell lung cancer. J Clin Invest 1993, 92(2):804-813.
127. Bambace N.M., Holmes C.E. The platelet contribution to cancer progression. J Thromb Haemost 2011, 9(2):237-249.
128. Erpenbeck L., Schon M.P. Deadly allies: the fatal interplay between platelets and metastasizing cancer cells. Blood 2010, 115(17):3427-3436.
129. Trikha M., Zhou Z., Timar J., Raso E., Kennel M., Emmell E., et al. Multiple roles for platelet GPIIb/IIIa and alphavbeta3 integrins in tumor growth, angiogenesis, and metastasis. Cancer Res 2002, 62(10):2824-2833.
130. Schumacher H.R. Synovial membrane and fluid morphologic alterations in early rheumatoid arthritis: microvascular injury and virus-like particles. Ann N Y Acad Sci 1975, 256:39-64.
131. Wang F., Wang N.S., Yan C.G., Li J.H., Tang L.Q. The significance of platelet activation in rheumatoid arthritis. Clin Rheumatol 2007, 26(5):768-771.
132. Knijff-Dutmer E.A., Koerts J., Nieuwland R., Kalsbeek-Batenburg E.M., van de Laar M.A. Elevated levels of platelet microparticles are associated with disease activity in rheumatoid arthritis. Arthritis Rheum 2002, 46(6):1498-1503.
133. Bunescu A., Seideman P., Lenkei R., Levin K., Egberg N. Enhanced Fcgamma receptor I, alphaMbeta2 integrin receptor expression by monocytes and neutrophils in rheumatoid arthritis: interaction with platelets. J Rheumatol 2004, 31(12):2347-2355.
134. Sellam J., Proulle V., Jungel A., Ittah M., Miceli Richard C., Gottenberg J.E., et al. Increased levels of circulating microparticles in primary Sjogren's syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activity. Arthritis Res Ther 2009, 11(5):R156.
135. Yaron M., Djaldetti M. Platelets in synovial fluid. Arthritis Rheum 1978, 21(5):607-608.
136. Endresen G.K., Forre O. Human platelets in synovial fluid. A focus on the effects of growth factors on the inflammatory responses in rheumatoid arthritis. Clin Exp Rheumatol 1992, 10(2):181-187.
137. Boilard E., Nigrovic P.A., Larabee K., Watts G.F., Coblyn J.S., Weinblatt M.E., et al. Platelets amplify inflammation in arthritis via collagen-dependent microparticle production. Science 2010, 327(5965):580-583.
138. Boilard E., Blanco P., Nigrovic P.A. Platelets: active players in the pathogenesis of arthritis and SLE. Nat Rev Rheumatol 2012, 8(9):534-542.
139. Flaumenhaft R. Platelet secretion. Platelets 2013, 343-366. Academic Press, Amsterdam. A.D. Michelson (Ed.).
140. McNicol A., Israels S.J. Platelet dense granules: structure, function and implications for haemostasis. Thromb Res 1999, 95(1):1-18.
141. Rendu F., Brohard-Bohn B. The platelet release reaction: granules' constituents, secretion and functions. Platelets 2001, 12(5):261-273.
142. Blair P., Flaumenhaft R. Platelet alpha-granules: basic biology and clinical correlates. Blood Rev 2009, 23(4):177-189.
143. Vasina E., Heemskerk J.W., Weber C., Koenen R.R. Platelets and platelet-derived microparticles in vascular inflammatory disease. Inflamm Allergy Drug Targets 2010, 9(5):346-354.
144. Bizzozero J. Ueber einen neuen Forrnbestandteil des Blutes und dessen Rolle bei der Thrombose und Blutgerinnung. Archiv fur pathologische Anatomie und Physiologie und fur klinische Medicin 1882, 90:261-332.